Fingerprint
Dive into the research topics of 'Phase II trial of weekly erlotinib dosing to reduce duodenal polyp burden associated with familial adenomatous polyposis'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase II trial of weekly erlotinib dosing to reduce duodenal polyp burden associated with familial adenomatous polyposis
N. Jewel Samadder, Nathan Foster, Ryan P. McMurray, Carol A. Burke, Elena Stoffel, Priyanka Kanth, Rohit Das, Marcia Cruz-Correa, E. Vilar, Gautam Mankaney, Navtej Buttar, Selvi Thirumurthi, Danielle K. Turgeon, Michael Sossenheimer, Michelle Westover, Ellen Richmond, Asad Umar, Gary Della'Zanna, Luz M. Rodriguez, Eva Szabo
Research output: Contribution to journal › Article › peer-review